A Day Up For NeuBase Therapeutics, Inc.

Fri, Feb 10, 2023 at 07:13 PM
A Day Up For NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc. (NBSE:NASDAQ) jumped higher at $0.33, representing a gain of 26.9%. On Fri, Feb 10, 2023, NBSE:NASDAQ touched a New 2-Week High of $0.33. From Fri, Jan 27, 2023, the stock recorded 50.00% Up Days and 36.36% Green Days

About NeuBase Therapeutics, Inc. (NBSE:NASDAQ)

Ohr Pharmaceutical Inc is a US-based pharmaceutical company which focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. The lead product of the company is topical Squalamine is a novel therapeutic product which provides non-invasive therapy to improve visual outcomes. Its product pipeline includes SQUALAMINE LACTATE OPHTHALMIC SOLUTION 0.2%, SKS sustained release ocular drug delivery platform technology, Animal Model for Dry-AMD, and Non-Ophthalmology Assets.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.